ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

Journal Editorial - PCSK9 inhibition for acute arterial events: more than LDL lowering

ESC Cardio Talk

13/12/2021 11 min

Journal Editorial - PCSK9 inhibition for acute arterial events: more than LDL lowering

Listen "Journal Editorial - PCSK9 inhibition for acute arterial events: more than LDL lowering"

Descargar episodio Ver en sitio original

Episode Synopsis

With Carl E Orringer & Jelani K Grant, University of Miami Miller School of Medicine, Miami - USA Link to paper Link to editorial

More episodes of the podcast ESC Cardio Talk

Journal editorial - The emerging story of Myval transcatheter heart valve: lessons from the LANDMARK trial 24/11/2025

Journal editorial: The dilemma of a correct patient selection for implantable cardioverter defibrillator in non-ischaemic cardiomyopathy 17/11/2025

Journal editorial: Is routine imaging follow-up after LAA closure necessary? 10/11/2025

Journal Editorial: Perioperative discontinuation of renin–angiotensin system inhibitors in non-cardiac surgery: is it time to change what we tell our patients? 20/10/2025

Journal editorial: Arrhythmic risk and advanced heart failure in dilated cardiomyopathy: a deadly tango 20/10/2025

Journal editorial: ApoB and Lp(a): core measures to assess cardiovascular risk 06/10/2025

Journal editorial: With a little HELP from heparin at first medical contact before primary percutaneous coronary intervention 29/09/2025

Journal editorial - Residual cardiovascular risk beyond low-density lipoprotein cholesterol: inflammation, remnant cholesterol, and lipoprotein(a) 15/09/2025

Journal editorial - Has artificial intelligence proven stress perfusion cardiac computed tomography obsolete or more relevant than ever? 04/08/2025

Journal editorial - When coronary plaque is found in everyone: is anyone really at risk? 12/07/2025

Ver todos los episodios